1-3 of 3
Gro Gausdal
Close
Sort by
Journal Articles

Single Cell Signaling Pharmacodynamics in a Phase 1b Trial of the Axl Inhibitor BGB324 in Acute Myeloid Leukemia

Monica Hellesøy, PhD, Stein-Erik Gullaksen, Benedicte Sjo Tislevoll, Oda Helen Eck Fagerholt, Hakon Reikvam, MD PhD, Sonja Loges, MD PhD, Jorge Cortes, MD, Michael Heuser, MD, Jörg Chromik, Jørn Skavland, PhD, André Sulen, Øystein Bruserud, MD PhD, Jim Lorens, PhD, Gro Gausdal, PhD, David Micklem, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3995.
https://doi.org/10.1182/blood.V128.22.3995.3995
Published: 2016
Journal Articles

Single Cell-Level Signaling Profiling of Acute Myeloid Leukemia Following Treatment with Axl Kinase Inhibitor BGB324

Monica Hellesøy, PhD, Katarzyna Wnuk-Lipinska, PhD, Anna Boniecka, MSc, Eline Milde Nævdal, Hakon Reikvam, MDPhD, Sonja Loges, MDPhD, Jorge E. Cortes, MD, Jørn Skavland, PhD, Øystein Bruserud, MDPhD, Jim Lorens, PhD, David Micklem, PhD, Gro Gausdal, PhD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4931.
https://doi.org/10.1182/blood.V126.23.4931.4931
Published: 2015
Journal Articles

Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death

Gro Gausdal, Bjørn Tore Gjertsen, Emmet McCormack, Petra Van Damme, Randi Hovland, Camilla Krakstad, Øystein Bruserud, Kris Gevaert, Joël Vandekerckhove, Stein Ove Døskeland
Journal: Blood
Blood (2008) 111 (5): 2866–2877.
https://doi.org/10.1182/blood-2007-07-103242
Published: 2008
Includes: Supplemental data